サンプル依頼リスト カート
  • English
  • Korean
表紙：世界の診断市場における人工知能：動向、機会、競合分析【2023-2028年】
市場調査レポート
商品コード
1342023

世界の診断市場における人工知能：動向、機会、競合分析【2023-2028年】

Artificial Intelligence in the Global Diagnostic Market: Trends, Opportunities and Competitive Analysis [2023-2028]

出版日
発行
Lucintel
ページ情報
英文 150 Pages
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

世界の診断市場における人工知能：動向、機会、競合分析【2023-2028年】
出版日: 2023年08月10日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

診断市場における人工知能の動向と予測

世界の診断市場における人工知能の将来性は、放射線学、腫瘍学、神経学＆心臓学、胸部＆肺、病理学市場におけるビジネスチャンスで有望視されています。世界の診断市場における人工知能の利用は、2023年から2028年までのCAGRが33.5%で、2028年までに推定38億米ドルに達すると予想されます。この市場の主な促進要因は、診断費用の削減ニーズの高まり、ヘルスケア分野の技術開拓、低コスト診断コンポーネントに対する需要の高まりです。

診断市場における人工知能の洞察

  • Lucintelの予測では、検査精度のヘルスケア診断用に設計されたAI駆動型ソフトウェアの進歩に加え、患者の医療画像を解釈しながら診断精度を大幅に向上させるためのAI対応およびクラウド中心の強化診断ソリューションへの要求が高まっていることから、予測期間中、ソフトウェアが最も高い成長を遂げる見込みです。
  • 神経学と心臓病学は、神経疾患の罹患率の上昇と、世界中で神経疾患の症例治療に価値に基づくケアを採用する傾向が強まっていることから、引き続き最大セグメントとなります。
  • 北米は、電子カルテ（EHR）、遠隔医療サービス、その他のデジタルヘルスケアソリューションの普及、AI主導の診断機器のシームレスな統合により、予測期間中も最大地域であり続けると思われます。

本レポートでは、以下の11の主要な質問に回答している：

  • Q1.診断市場における人工知能のコンポーネント別（ハードウェア、ソフトウェア、サービス）、技術別（機械学習、NLP、コンテクストを考慮したコンピューティング、コンピュータビジョン）、診断タイプ別（放射線学、腫瘍学、神経学＆心臓学、胸部＆肺、病理学、その他）、地域別（北米、欧州、アジア太平洋地域、世界のその他の地域）で、最も有望で高い成長機会があるものは何か？
  • Q.2.今後成長が加速するセグメントとその理由は？
  • Q.3.成長ペースが速いと思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？また、主要企業はどのような戦略的取り組みを進めているのでしょうか。
  • Q10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度あるのか？
  • Q11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の診断市場における人工知能：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2017年から2028年までの市場動向と予測分析

  • マクロ経済動向（2017～2022年）と予測（2023～2028年）
  • 世界の診断市場における人工知能の動向（2017-2022）と予測（2023-2028）
  • コンポーネント別の世界の診断市場における人工知能
    • ハードウェア
    • ソフトウェア
    • サービス
  • 世界の診断市場における人工知能の技術別分析
    • 機械学習
    • NLP
    • コンテキストアウェアコンピューティング
    • コンピュータビジョン
  • 診断タイプ別の世界の診断市場における人工知能
    • 放射線科
    • 腫瘍学
    • 神経内科と循環器内科
    • 胸部と肺
    • 病理学
    • その他

第4章 2017年から2028年までの地域別の市場動向と予測分析

  • 地域別の世界の診断市場における人工知能
  • 北米の診断市場における人工知能
  • 欧州の診断市場における人工知能
  • アジア太平洋診断市場における人工知能
  • その他地域診断市場における人工知能

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • コンポーネント別の世界の診断市場における人工知能の成長機会
    • 技術別の世界の診断市場における人工知能の成長機会
    • 診断タイプ別の世界の診断市場における人工知能の成長機会
    • 地域別の世界の診断市場における人工知能の成長機会
  • 世界の診断市場における人工知能の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の診断市場における人工知能の能力拡大
    • 世界の診断市場における人工知能の合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • General Electric
  • Siemens
  • Aidoc Medical
  • AliveCor
  • Imagen Technologies
  • VUNO
  • IDx Technologies
  • NovaSignal Corporation
  • Riverain Technologies
  • Zebra Medical Vision
目次

Artificial Intelligence in the Diagnostic Market Trends and Forecast

The future of artificial intelligence in the global diagnostic market looks promising with opportunities in the radiology, oncology, neurology & cardiology, chest & lung, and pathology markets. The use of artificial intelligence in the global diagnostic market is expected to reach an estimated $3.8 billion by 2028 with a CAGR of 33.5% from 2023 to 2028. The major drivers for this market are increasing need to lower diagnostic expenses, technological developments in the healthcare sector, and rising demand for low-cost diagnostic components.

A more than 150-page report is developed to help in your business decisions.

Artificial Intelligence in the Diagnostic Market by Segment

The study includes trends and forecast for artificial intelligence in the global diagnostic market by component, technology, diagnosis type, and region as follows:

Artificial Intelligence in the Diagnostic Market by Component [Shipment Analysis by Value from 2017 to 2028]:

  • Hardware
  • Software
  • Services

Artificial Intelligence in the Diagnostic Market by Technology [Shipment Analysis by Value from 2017 to 2028]:

  • Machine Learning
  • NLP
  • Context-Aware Computing
  • Computer Vision

Artificial Intelligence in the Diagnostic Market by Diagnosis Type [Shipment Analysis by Value from 2017 to 2028]:

  • Radiology
  • Oncology
  • Neurology & Cardiology
  • Chest & Lungs
  • Pathology
  • Others

Artificial Intelligence in the Diagnostic Market by Region [Shipment Analysis by Value from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Artificial Intelligence Companies in the Diagnostic Market

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, artificial intelligence companies in the diagnostic market cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of artificial intelligence companies in the diagnostic market profiled in this report include:

  • General Electric
  • Siemens
  • Aidoc Medical
  • AliveCor
  • Imagen Technologies
  • VUNO
  • IDx Technologies
  • NovaSignal Corporation
  • Riverain Technologies
  • Zebra Medical Vision

Artificial Intelligence in the Diagnostic Market Insights

  • Lucintel forecasts that software is expected to witness the highest growth over the forecast period due to advancement of AI-driven software designed for healthcare diagnosis in test accuracy, as well as increasing requirement for AI-enabled and cloud-centric enhanced diagnostic solutions to improve diagnostic accuracy significantly while interpreting medical imagery of patients.
  • Neurology & cardiology will remain the largest segment due to rising incidence of neurological disorders and increasing trend of adopting value based care in treating the cases of neurological disorders across the globe.
  • North America will remain the largest region over the forecast period due to widespread incorporation of electronic health records (EHRs), telehealth offerings, and additional digital healthcare solutions, as well as seamless integration of AI-driven diagnostic instruments.

Features of Artificial Intelligence in the Diagnostic Market

  • Market Size Estimates: Artificial intelligence in the diagnostic market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions.
  • Segmentation Analysis: Artificial intelligence in the diagnostic market size by various segments, such as by component, technology, diagnosis type, and region in terms of value ($B).
  • Regional Analysis: Artificial intelligence in the diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different components, technologies, diagnosis types, and regions for artificial intelligence in the diagnostic market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of artificial intelligence in the diagnostic market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

  • Q1. What is artificial intelligence in the diagnostic market size?
  • Answer: The use of artificial intelligence in the global diagnostic market is expected to reach an estimated $3.8 billion by 2028.
  • Q2.What is the growth forecast for artificial intelligence in the diagnostic market?
  • Answer: The use of artificial intelligence in the global diagnostic market is expected to grow with a CAGR of 33.5% from 2023 to 2028.
  • Q3.What are the major drivers influencing the growth of artificial intelligence in the diagnostic market?
  • Answer: The major drivers for this market are increasing need to lower diagnostic expenses, technological developments in the healthcare sector, and rising demand for low-cost diagnostic components.
  • Q4. What are the major segments for artificial intelligence in the diagnostic market?
  • Answer: The future of artificial intelligence in the diagnostic market looks promising with opportunities in the radiology, oncology, neurology & cardiology, chest & lung, and pathology markets.
  • Q5. Who are the key artificial intelligence companies in the diagnostic market?
  • Answer: Some of the key artificial intelligence companies in the diagnostic market are as follows:
    • General Electric
    • Siemens
    • Aidoc Medical
    • AliveCor
    • Imagen Technologies
    • VUNO
    • IDx Technologies
    • NovaSignal Corporation
    • Riverain Technologies
    • Zebra Medical Vision
  • Q6. Which segment in the diagnostic market in terms of artificial Intelligence usage will be the largest in future?
  • Answer: Lucintel forecasts that software is expected to witness the highest growth over the forecast period due to advancement of AI-driven software designed for healthcare diagnosis in test accuracy, as well as increasing requirement for AI-enabled and cloud-centric enhanced diagnostic solutions to improve diagnostic accuracy significantly while interpreting medical imagery of patients.
  • Q7. In the diagnostic market in terms of artificial Intelligence usage, which region is expected to be the largest in next 5 years?
  • Answer: North America will remain the largest region over the forecast period due to widespread incorporation of electronic health records (EHRs), telehealth offerings, and additional digital healthcare solutions, as well as seamless integration of AI-driven diagnostic instruments.
  • Q.8. Do we receive customization in this report?
  • Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

  • Q1. What are some of the most promising, high-growth opportunities for artificial intelligence in the diagnostic market by component (hardware, software, and services), technology (machine learning, NLP, context-aware computing, computer vision), diagnosis type (radiology, oncology, neurology & cardiology, chest & lungs, pathology, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Artificial Intelligence in the Global Diagnostic Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Artificial Intelligence in the Global Diagnostic Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Artificial Intelligence in the Global Diagnostic Market by Component
    • 3.3.1: Hardware
    • 3.3.2: Software
    • 3.3.3: Services
  • 3.4: Artificial Intelligence in the Global Diagnostic Market by Technology
    • 3.4.1: Machine Learning
    • 3.4.2: NLP
    • 3.4.3: Context-Aware Computing
    • 3.4.4: Computer Vision
  • 3.5: Artificial Intelligence in the Global Diagnostic Market by Diagnosis Type
    • 3.5.1: Radiology
    • 3.5.2: Oncology
    • 3.5.3: Neurology & Cardiology
    • 3.5.4: Chest & Lungs
    • 3.5.5: Pathology
    • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Artificial Intelligence in the Global Diagnostic Market by Region
  • 4.2: Artificial Intelligence in the North American Diagnostic Market
    • 4.2.1: Artificial Intelligence in the North American Diagnostic Market by Component: Hardware, Software, and Services
    • 4.2.2: Artificial Intelligence in the North American Diagnostic Market by Diagnosis Type: Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology, and Others
  • 4.3: Artificial Intelligence in the European Diagnostic Market
    • 4.3.1: Artificial Intelligence in the European Diagnostic Market by Component: Hardware, Software, and Services
    • 4.3.2: Artificial Intelligence in the European Diagnostic Market by Diagnosis Type: Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology, and Others
  • 4.4: Artificial Intelligence in the APAC Diagnostic Market
    • 4.4.1: Artificial Intelligence in the APAC Diagnostic Market by Component: Hardware, Software, and Services
    • 4.4.2: Artificial Intelligence in the APAC Diagnostic Market by Diagnosis Type: Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology, and Others
  • 4.5: Artificial Intelligence in the ROW Diagnostic Market
    • 4.5.1: Artificial Intelligence in the ROW Diagnostic Market by Component: Hardware, Software, and Services
    • 4.5.2: Artificial Intelligence in the ROW Diagnostic Market by Diagnosis Type: Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for Artificial Intelligence in the Global Diagnostic Market by Component
    • 6.1.2: Growth Opportunities for Artificial Intelligence in the Global Diagnostic Market by Technology
    • 6.1.3: Growth Opportunities for Artificial Intelligence in the Global Diagnostic Market by Diagnosis Type
    • 6.1.4: Growth Opportunities for Artificial Intelligence in the Global Diagnostic Market by Region
  • 6.2: Emerging Trends of Artificial Intelligence in the Global Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of Artificial Intelligence in the Global Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures of Artificial Intelligence in the Global Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: General Electric
  • 7.2: Siemens
  • 7.3: Aidoc Medical
  • 7.4: AliveCor
  • 7.5: Imagen Technologies
  • 7.6: VUNO
  • 7.7: IDx Technologies
  • 7.8: NovaSignal Corporation
  • 7.9: Riverain Technologies
  • 7.10: Zebra Medical Vision